Clinical Trial Update: Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging [Phase 3]

View source ↗

Summary

Phase 3 trial of Dehydroepiandrosterone (DHEA) for treating ovarian aging in infertility has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diminished Ovarian Reserve
• Infertility
• Poor Ovarian Response

Drugs mentioned

• Dehydroepiandrosterone (DHEA) (dehydroepiandrosterone)

Snippet

Sponsor: University of Nottingham | Conditions: Infertility, Ovarian Aging | Phase 3 | Status: COMPLETED